Immunotech Biopharm Ltd
HKEX:6978.HK
1.52 (HKD) • At close November 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Immunotech Biopharm Ltd |
Symbool | 6978.HK |
Munteenheid | HKD |
Prijs | 1.52 |
Beurswaarde | 782,167,678 |
Dividendpercentage | 0% |
52-weken bereik | 1.5 - 5 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Yu Wang |
Website | https://www.eaal.net |
An error occurred while fetching data.
Over Immunotech Biopharm Ltd
Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China. Its core product is EAL, a multi-target cellular immunotherapy product that is in Phase II clinical trials for the
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (HKD)
Cijfers zijn in miljoenen (HKD)